Researchers have developed FRW, a peptide that can bind to blood vessels without binding to other organs; this could lead to novel imaging techniques for neurodegenerative diseases.
Browsing: Cognitive/neurodegenerative disorders
A recent clinical trial has demonstrated that the drug, IONIS-HTTRx, is safe for use in people with Huntington’s disease.
Whilst at the ARUK Conference 2019, we had the pleasure of speaking with Hugh Perry about neuroinflammation and Alzheimer’s disease, particularly the role of microglia in brain homeostasis.
A preliminary clinical study has demonstrated that the experimental drug tofersen may be effective in the treatment of a genetic form of ALS.
Researchers have developed a device that utilizes brain activity to control a virtual vocal tract; this could enhance the communication of individuals who have lost the ability to speak.
Home technology including artificial intelligence, robotics and sleep monitoring may become standard in the homes of people living with dementia, researchers indicate.
An experimental PET scan was used to detect elevated levels of abnormal tau protein in regions of the brain affected by CTE in living former NFL players.
A recently published study has indicated that electrostimulation can help boost elder people’s mental scores to those of people 20–30 years younger.
Couldn’t attend the AD/PD™ 2019 Congress? Our Editor, Sharon Salt, provides her key highlights and takeaway messages from the event.